Ultrasound Guided Autologous Blood Injection in Temporomandibular Joint Dislocation

Save

Report Abuse

Description

The aim of this study is To compare the accuracy and effectiveness of ultrasound (US) guided autologous blood injection (ABI) versus non- guided technique for the treatment of chronic recurrent temporomandibular joint dislocation

Study Overview

Start Date
January 1, 2024
Completion Date
December 1, 2024
Enrollment
24
Date Posted
February 6, 2024
Accepts Healthy Volunteers?
Yes
Gender
All

Locations

Full Address
faculty of dentistry, Cairo university
Cairo, Egypt

Eligibility

Minimum Age (years)
18
Eligibility Criteria
Inclusion Criteria:

Patient with at least 3 episodes of temporomandibular joint dislocation in the past 6 months.
Necessitating a visit to the emergency room or trained professional to reduce the dislocation.
Radiological evidence of displacement of condylar head beyond the articular eminence on wide mouth opening.
Maximum mouth opening (MMO) more than 40 mm.
Unilateral or bilateral.
Over 18 years of age.
Both gender Males or females.

Exclusion Criteria:

Patient having inflammatory temporomandibular joint disease like tuberculous arthritis, rheumatoid arthritis.
Patients with bleeding disorders, pregnancy or bony pathology of temporomandibular joint .
Allergy to local anesthetic.
Severe epilepsy or Parkinson's disease.
Patient on anti-depressants or anti-psychotics.
Inability to follow-up the patient during the entire follow-up period.
Patients who had recent fracture at temporomandibular joint level or who had previous surgical interference to temporomandibular joint .
Refused to sign the written informed consent were also excluded.
Dystonia

Study Contact Info

Study Contact Name
Mohamed Abbas, bachelor
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

Ultrasound Guided Autologous Blood Injection in Temporomandibular Joint Dislocation 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
Detailed Description
All patients involved in this study will be divided randomly to two different groups and injected with autologous blood into joint space and pericapsular tissue.

Study group (group A) will be injected with autologous blood with ultrasound guidance.

control group (group B) will be injected with autologous blood without US guidance. Anatomical landmarks and tactical sense will be followed only.

The operation will be done under local anesthesia ( Auriculotemporal nerve block ) the skin overlying the temporomandibular joint will be scrubbed by an antiseptic solution and the area will be isolated with sterile towels. External auditory canal will be blocked with cotton.

About 3 ml of blood will be withdrawn from patient's antecubital fossa, of which 2 ml injected intra-articular and 1 ml in the pericapsular tissue (PT) The procedure should be repeated on the opposite side in case of bilateral involvement.
NCTid (if applicable)
NCT06244134